Antibody-Based Synthetic Cannabinoid Detection Kits
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting synthetic cannabinoids, such as JWH and CP compounds, are inadequate for rapid and cost-effective identification and quantification, especially in herbal therapeutics and patient samples, due to their structural similarities and the need for specialized equipment and staff.
Innovation Solution
Development of novel antibodies raised against specific immunogens that bind to JWH and CP molecules and their metabolites, enabling rapid and economic detection and quantification using immunoassay kits and biochips.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If GC-MS/LC-MS techniques are used for detection, then measurement precision is improved, but device complexity and cost increase
Solution Approach 1:
The patent replaces complex instrumental analysis systems (GC-MS/LC-MS) with a biological recognition system using antibodies that specifically bind to synthetic cannabinoids. This immunological approach substitutes mechanical/optical detection systems with biochemical interaction-based detection, achieving comparable or sufficient precision while dramatically reducing equipment complexity and operational requirements.
2Measurement precision
If pre-derivatisation and solvent extraction are used, then measurement precision is improved, but loss of time and productivity decrease
Solution Approach 1:
The patent performs preliminary action by pre-coating assay wells with antibodies specific to synthetic cannabinoids before sample analysis. This pre-preparation creates ready-to-use detection platforms that eliminate time-consuming sample pre-treatment steps like derivatisation and extraction, allowing direct analysis while maintaining detection accuracy through the pre-positioned specific binding agents.
3Measurement precision
If specialist staff and expensive equipment are required, then measurement precision is improved, but ease of operation deteriorates
Solution Approach 1:
The patent employs disposable immunoassay kits with pre-coated antibodies and integrated reagents that eliminate the need for expensive, maintainable equipment and highly trained specialists. These single-use kits provide reliable detection through standardized protocols that can be performed by personnel with minimal training, sacrificing the potential ultra-high precision of reusable instrumental systems for operational simplicity and cost-effectiveness.
4Measurement precision
If structural characterisation studies are conducted, then measurement precision is improved, but loss of time and productivity decrease
Solution Approach 1:
The patent creates universal antibodies that recognize multiple synthetic cannabinoids and their metabolites through common structural features (indole or naphthyl rings with specific substituents). This multi-functional antibody approach enables simultaneous detection and structural identification of various compounds in a single assay, eliminating the need for separate, time-consuming characterisation studies for each individual compound while maintaining high identification accuracy and dramatically increasing detection throughput.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The antibodies provide effective detection and quantification of known and future synthetic cannabinoids, including metabolites, in both herbal samples and patient samples, overcoming the limitations of existing detection techniques.
Implementation Method 1
novel antibodies raised from novel immunogens. The antibodies underpin an effective analytical and economic solution to the detection and quantification of current and future JWH and CP CB1-active molecules
Data Source
AI summary
The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.